Krystal Biotech, Inc. (KRYS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 7.14B |
| Enterprise Value | 6.65B |
| P/E Ratio | 41.91 |
| PEG Ratio | 0.67 |
| Price/Sales Ratio | 23.2 |
| Price/Book Ratio | 7.53 |
| Enterprise/Revenue | 22.24 |
| Enterprise/EBITDA | 44.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.55 |
| Operating Margin | 0.45 |
| Return On Assets | 0.16 |
| Return On Equity | 0.19 |
| Revenue | 389.13M |
| Revenue/Share | 14.92 |
| Gross Profit | 360.36M |
| EBITDA | 196.02M |
| Net Income | 204.83M |
| Diluted EPS | 6.84 |
| Total Cash | 845.63M |
| Total Cash/Share | 28.64 |
| Total Debt | 8.85M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.32 |
| Book Value Per Share | 46.03 |
| 52-Week Change | 130.3 |
| 52-Week High | 382.54 |
| 52-Week Low | 136.73 |
| Moving Average 50 Days | 345.35 |
| Moving Average 200 Days | 282.49 |
| Average Volume | 413,543 |
| Shares Outstanding | 29.48M |
| % Held by Institutions | 104.18 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |